; Whereas Federal law severely limits access to loans and capital for cannabis businesses, disproportionately impacting minority small business owners; Whereas the World Health Organization reported that about 2.5 percent of the global population use cannabis, and disparate legal outcomes pertaining to the substance have been replicated in foreign states; Whereas cannabis and cannabis resin, including extracts and tinctures of cannabis, are classified by the United Nations (UN) as a Schedule I drug under UN drug control treaties such as the Single Convention on Narcotic Drugs; Whereas the classification of cannabis as a Schedule I drug is outdated and the U.S. should be leading the way on cannabis reform at the multilateral level; Whereas foreign states such as Canada, Luxembourg, Malta, Thailand, and Uruguay have legalized cannabis for recreational use, and multiple others including Mexico, Georgia, Germany, Ghana, and South Africa have taken steps to legalize cannabis; Whereas additional foreign states would reevaluate how cannabis is classified in their countries if the United Nations did so; and Whereas an increasing number of States and municipalities have taken proactive steps to acknowledge and address the harms of cannabis criminalization, advance equity in cannabis policy, and mitigate inequalities in the legal cannabis marketplace: Now, therefore, be it